Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

Similar articles for PubMed (Select 18263783)

1.

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.

Ekström Smedby K, Vajdic CM, Falster M, Engels EA, Martínez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett E, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjosé S, Chiu BC, Dal Maso L, Cocco P, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Grulich AE, Cozen W.

Blood. 2008 Apr 15;111(8):4029-38. doi: 10.1182/blood-2007-10-119974. Epub 2008 Feb 8.

2.

Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.

Smedby KE, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald A, Sundström C, Akerman M, Melbye M, Glimelius B, Adami HO.

J Natl Cancer Inst. 2006 Jan 4;98(1):51-60.

3.

Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma.

Mellemkjaer L, Pfeiffer RM, Engels EA, Gridley G, Wheeler W, Hemminki K, Olsen JH, Dreyer L, Linet MS, Goldin LR, Landgren O.

Arthritis Rheum. 2008 Mar;58(3):657-66. doi: 10.1002/art.23267.

4.

Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study.

Fallah M, Liu X, Ji J, Försti A, Sundquist K, Hemminki K.

Ann Oncol. 2014 Oct;25(10):2025-30. doi: 10.1093/annonc/mdu365. Epub 2014 Jul 31.

PMID:
25081899
5.

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjosé S, Smedby KE, Chiu BC, Zhang Y, Mbulaiteye SM, Monnereau A, Turner JJ, Clavel J, Adami HO, Chang ET, Glimelius B, Hjalgrim H, Melbye M, Crosignani P, di Lollo S, Miligi L, Nanni O, Ramazzotti V, Rodella S, Costantini AS, Stagnaro E, Tumino R, Vindigni C, Vineis P, Becker N, Benavente Y, Boffetta P, Brennan P, Cocco P, Foretova L, Maynadié M, Nieters A, Staines A, Colt JS, Cozen W, Davis S, de Roos AJ, Hartge P, Rothman N, Severson RK, Holly EA, Call TG, Feldman AL, Habermann TM, Liebow M, Blair A, Cantor KP, Kane EV, Lightfoot T, Roman E, Smith A, Brooks-Wilson A, Connors JM, Gascoyne RD, Spinelli JJ, Armstrong BK, Kricker A, Holford TR, Lan Q, Zheng T, Orsi L, Dal Maso L, Franceschi S, La Vecchia C, Negri E, Serraino D, Bernstein L, Levine A, Friedberg JW, Kelly JL, Berndt SI, Birmann BM, Clarke CA, Flowers CR, Foran JM, Kadin ME, Paltiel O, Weisenburger DD, Linet MS, Sampson JN.

J Natl Cancer Inst Monogr. 2014 Aug;2014(48):130-44. doi: 10.1093/jncimonographs/lgu013.

PMID:
25174034
6.

Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.

Engels EA, Cerhan JR, Linet MS, Cozen W, Colt JS, Davis S, Gridley G, Severson RK, Hartge P.

Am J Epidemiol. 2005 Dec 15;162(12):1153-61. Epub 2005 Oct 26.

7.

Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies.

Anderson LA, Gadalla S, Morton LM, Landgren O, Pfeiffer R, Warren JL, Berndt SI, Ricker W, Parsons R, Engels EA.

Int J Cancer. 2009 Jul 15;125(2):398-405. doi: 10.1002/ijc.24287.

8.

Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.

Wang SS, Davis S, Cerhan JR, Hartge P, Severson RK, Cozen W, Lan Q, Welch R, Chanock SJ, Rothman N.

Carcinogenesis. 2006 Sep;27(9):1828-34. Epub 2006 Mar 16.

9.

The risk of lymphoma development in autoimmune diseases: a meta-analysis.

Zintzaras E, Voulgarelis M, Moutsopoulos HM.

Arch Intern Med. 2005 Nov 14;165(20):2337-44. Review.

PMID:
16287762
10.

Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.

Vajdic CM, Falster MO, de Sanjose S, Martínez-Maza O, Becker N, Bracci PM, Melbye M, Smedby KE, Engels EA, Turner J, Vineis P, Costantini AS, Holly EA, Kane E, Spinelli JJ, La Vecchia C, Zheng T, Chiu BC, Dal Maso L, Cocco P, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Cozen W, Grulich AE.

Cancer Res. 2009 Aug 15;69(16):6482-9. doi: 10.1158/0008-5472.CAN-08-4372. Epub 2009 Aug 4.

11.

Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.

Landgren O, Engels EA, Pfeiffer RM, Gridley G, Mellemkjaer L, Olsen JH, Kerstann KF, Wheeler W, Hemminki K, Linet MS, Goldin LR.

J Natl Cancer Inst. 2006 Sep 20;98(18):1321-30.

12.

The association of immune disease and malignant lymphoma.

Miller DG.

Ann Intern Med. 1967 Mar;66(3):507-21. No abstract available.

PMID:
4959981
13.

Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.

Wang SS, Vajdic CM, Linet MS, Slager SL, Voutsinas J, Nieters A, de Sanjose S, Cozen W, Alarcón GS, Martinez-Maza O, Brown EE, Bracci PM, Lightfoot T, Turner J, Hjalgrim H, Spinelli JJ, Zheng T, Morton LM, Birmann BM, Flowers CR, Paltiel O, Becker N, Holly EA, Kane E, Weisenburger D, Maynadie M, Cocco P, Foretova L, Staines A, Davis S, Severson R, Cerhan JR, Breen EC, Lan Q, Brooks-Wilson A, De Roos AJ, Smith MT, Roman E, Boffetta P, Kricker A, Zhang Y, Skibola C, Chanock SJ, Rothman N, Benavente Y, Hartge P, Smedby KE.

Am J Epidemiol. 2015 Mar 15;181(6):406-21. doi: 10.1093/aje/kwu290. Epub 2015 Feb 23. Review.

PMID:
25713336
14.

Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women.

Zhang Y, Holford TR, Leaderer B, Zahm SH, Boyle P, Morton LM, Zhang B, Zou K, Flynn S, Tallini G, Owens PH, Zheng T.

Cancer Causes Control. 2004 May;15(4):419-28.

PMID:
15141141
15.

Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.

Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM.

Medicine (Baltimore). 2009 Sep;88(5):284-93. doi: 10.1097/MD.0b013e3181b76ab5.

PMID:
19745687
16.

Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.

Morton LM, Sampson JN, Cerhan JR, Turner JJ, Vajdic CM, Wang SS, Smedby KE, de Sanjosé S, Monnereau A, Benavente Y, Bracci PM, Chiu BC, Skibola CF, Zhang Y, Mbulaiteye SM, Spriggs M, Robinson D, Norman AD, Kane EV, Spinelli JJ, Kelly JL, La Vecchia C, Dal Maso L, Maynadié M, Kadin ME, Cocco P, Costantini AS, Clarke CA, Roman E, Miligi L, Colt JS, Berndt SI, Mannetje A, de Roos AJ, Kricker A, Nieters A, Franceschi S, Melbye M, Boffetta P, Clavel J, Linet MS, Weisenburger DD, Slager SL.

J Natl Cancer Inst Monogr. 2014 Aug;2014(48):1-14. doi: 10.1093/jncimonographs/lgu005.

PMID:
25174022
17.

A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.

Löfström B, Backlin C, Sundström C, Ekbom A, Lundberg IE.

Ann Rheum Dis. 2007 Dec;66(12):1627-32. Epub 2007 May 21.

18.

Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome.

Anaya JM, McGuff HS, Banks PM, Talal N.

Semin Arthritis Rheum. 1996 Apr;25(5):337-46. Review.

PMID:
8778989
19.

Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.

Wang SS, Cozen W, Cerhan JR, Colt JS, Morton LM, Engels EA, Davis S, Severson RK, Rothman N, Chanock SJ, Hartge P.

Cancer Res. 2007 May 15;67(10):5042-54.

20.

The epidemiology of non-Hodgkin lymphoma.

Grulich AE, Vajdic CM.

Pathology. 2005 Dec;37(6):409-19. Review.

PMID:
16373224
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk